Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VERV Verve Therapeutics

交易中 11-22 15:35:48 EST

4.74

+0.14

+3.04%

最高4.87	最低4.50	成交量71.68万
今开4.50	昨收4.60	日振幅7.93%
总市值4.01亿	流通市值2.98亿	总股本8,466万
成交额336.62万	换手率1.14%	流通股本6,284万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":4.74,"timestamp":1732307747260,"preClose":4.6,"halted":0,"volume":716815,"delay":0,"floatShares":62842835,"shares":84663840,"eps":-2.449573,"marketStatus":"交易中","marketStatusCode":2,"change":0.14,"latestTime":"11-22 15:35:48 EST","open":4.5,"high":4.865,"low":4.5,"amount":3366237.78876,"amplitude":0.079348,"askPrice":4.75,"askSize":390,"bidPrice":4.74,"bidSize":650,"shortable":3,"etf":0,"ttmEps":-2.449573,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1623902400000,"adjPreClose":4.6,"preHourTrading":{"tag":"盘前","latestPrice":4.5,"preClose":4.6,"latestTime":"09:27 EST","volume":1372,"amount":6250.495448399999,"timestamp":1732285670035},"postHourTrading":{"tag":"盘后","latestPrice":4.64,"preClose":4.6,"latestTime":"19:19 EST","volume":45051,"amount":207592.0088,"timestamp":1732234761517},"volumeRatio":0.37623,"impliedVol":2.7091,"impliedVolPercentile":0.9722},"requestUrl":"/m/hq/s/VERV","defaultTab":"news","newsList":[{"id":"2485299509","title":"Verve Therapeutics, Inc.盘中异动 股价大涨5.33%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485299509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485299509?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:04","pubTimestamp":1732295059,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时04分，Verve Therapeutics, Inc.股票出现异动，股价快速上涨5.33%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1819.46%、145.08%、91.98%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为70.17%、63.64%、46.37%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123010420abd7cf96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123010420abd7cf96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","VERV"],"gpt_icon":0},{"id":"2485210081","title":"Verve Therapeutics, Inc.盘中异动 下午盘大幅跳水5.06%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485210081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485210081?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:18","pubTimestamp":1732130312,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时18分，Verve Therapeutics, Inc.股票出现波动，股价快速下跌5.06%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1855.59%、1326.33%、976.36%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103183398e43cc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103183398e43cc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2484600952","title":"Verve Therapeutics, Inc.盘中异动 下午盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484600952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484600952?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:25","pubTimestamp":1731957929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时25分，Verve Therapeutics, Inc.股票出现异动，股价大幅跳水5.01%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032529971a7427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032529971a7427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VERV","LENZ","BK4539"],"gpt_icon":0},{"id":"2483085659","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.15%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483085659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483085659?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:01","pubTimestamp":1731524482,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时01分，Verve Therapeutics, Inc.股票出现波动，股价大幅跳水5.15%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114030123971a65ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114030123971a65ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2482673262","title":"Verve Therapeutics, Inc.2024财年第三财季实现净利润-50.13百万美元，同比减少9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482673262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482673262?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254422,"startTime":"0","endTime":"0","summary":"11月11日，Verve Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-50.13百万美元，同比减少9.55%；其中营业收入为6.87百万美元，同比增加120.19%，每股基本收益为-0.59美元。从资产负债表来看，Verve Therapeutics, Inc.总负债1.55亿美元，其中短期债务10.37百万美元，资产负债比为4.29，流动比率为0.14。机构评级：截至2024年11月11日，当前有9家机构对Verve Therapeutics, Inc.目标价做出预测，其中目标均价为24.78美元，其中最低目标价为14.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000032a229e372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000032a229e372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VERV"],"gpt_icon":0},{"id":"2481793182","title":"Verve Therapeutics, Inc.盘中异动 早盘快速下跌5.17%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481793182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481793182?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:16","pubTimestamp":1730992598,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时16分，Verve Therapeutics, Inc.股票出现异动，股价快速下挫5.17%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107231638971a51eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107231638971a51eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","VERV","LENZ"],"gpt_icon":0},{"id":"2480582348","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480582348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480582348?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分，Verve Therapeutics, Inc.股票出现波动，股价急速下挫5.06%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Disc Medicine, Inc.、Neurogene Inc.、Tenaya Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为255.48%、198.38%、55.03%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225258ab9ec85b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225258ab9ec85b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2478894694","title":"Verve Therapeutics, Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478894694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478894694?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:44","pubTimestamp":1730123099,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时44分，Verve Therapeutics, Inc.股票出现波动，股价快速上涨5.19%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214459a1f2548f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214459a1f2548f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VERV","LENZ","BK4539"],"gpt_icon":0},{"id":"2478931050","title":"Verve Therapeutics, Inc.盘中异动 急速拉升5.24%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478931050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478931050?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:41","pubTimestamp":1729867260,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时41分，Verve Therapeutics, Inc.股票出现波动，股价急速拉升5.24%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025224100971a25aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025224100971a25aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","VERV","LENZ"],"gpt_icon":0},{"id":"2476617455","title":"Verve Therapeutics, Inc.盘中异动 早盘急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476617455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476617455?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:28","pubTimestamp":1729175296,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时28分，Verve Therapeutics, Inc.股票出现异动，股价大幅下挫5.00%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017222816a1e16abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017222816a1e16abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2473120960","title":"Verve Therapeutics, Inc.盘中异动 下午盘急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473120960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473120960?lang=zh_cn&edition=full","pubTime":"2024-10-05 01:23","pubTimestamp":1728062628,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日01时23分，Verve Therapeutics, Inc.股票出现异动，股价快速上涨5.08%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050123489719e6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050123489719e6db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2460824154","title":"Verve Therapeutics, Inc.2024财年第二财季实现净利润-49.81百万美元，同比增加7.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460824154","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460824154?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824038,"startTime":"0","endTime":"0","summary":"8月17日，Verve Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-49.81百万美元，同比增加7.73%；其中营业收入为6.69百万美元，同比增加220.10%，每股基本收益为-0.59美元。从资产负债表来看，Verve Therapeutics, Inc.总负债1.55亿美元，其中短期债务10.29百万美元，资产负债比为4.53，流动比率为0.15。机构评级：截至2024年8月17日，当前有9家机构对Verve Therapeutics, Inc.目标价做出预测，其中目标均价为25.11美元，其中最低目标价为15.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000614959f2d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000614959f2d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VERV"],"gpt_icon":0},{"id":"2459842793","title":"Verve Therapeutics, Inc.盘中异动 大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459842793","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459842793?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728644,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，Verve Therapeutics, Inc.股票出现异动，股价大幅拉升5.45%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2128.10%、1428.93%、329.34%，振幅较大的相关个股有Celcuity Inc.、Tyra Biosciences, Inc.、Vaxart, Inc. - Common Stock，振幅分别为9.31%、5.10%、5.07%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213044ab5dd814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213044ab5dd814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2459393681","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459393681","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459393681?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:14","pubTimestamp":1723479254,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日00时14分，Verve Therapeutics, Inc.股票出现波动，股价急速下挫5.01%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081300141498e34d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081300141498e34d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2458134445","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458134445","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458134445?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:37","pubTimestamp":1723135042,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时37分，Verve Therapeutics, Inc.股票出现异动，股价快速跳水5.11%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.82%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为405.56%、292.56%、185.98%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为126.67%、54.41%、45.58%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003722af96a31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003722af96a31b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","VERV","BK4139"],"gpt_icon":0},{"id":"2457577595","title":"Verve Therapeutics, Inc.盘中异动 快速下挫8.72%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457577595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457577595?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864796,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Verve Therapeutics, Inc.股票出现异动，股价急速跳水8.72%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为983.82%、35.96%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为13.04%、12.19%、11.60%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213316957f2ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213316957f2ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2456459404","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456459404","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456459404?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:50","pubTimestamp":1722531045,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时50分，Verve Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为1830.01%、346.38%、211.64%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Virax Biolabs Group Limited、Biomea Fusion, Inc.，振幅分别为57.55%、43.37%、43.27%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802005045af9566c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802005045af9566c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","VERV","LENZ"],"gpt_icon":0},{"id":"2454534054","title":"Verve Therapeutics, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454534054","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454534054?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:37","pubTimestamp":1722001024,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时37分，Verve Therapeutics, Inc.股票出现波动，股价大幅上涨5.61%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3220.08%、102.11%、35.59%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为45.29%、39.67%、20.82%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213705aefbb1d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213705aefbb1d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","VERV","BK4139"],"gpt_icon":0},{"id":"2453819018","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453819018","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453819018?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:03","pubTimestamp":1721833428,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时03分，Verve Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7603.19%、1195.53%、622.49%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.46%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724230348941fa2ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724230348941fa2ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VERV","LENZ","BK4539"],"gpt_icon":0},{"id":"2453056890","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453056890","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453056890?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:34","pubTimestamp":1721745268,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日22时34分，Verve Therapeutics, Inc.股票出现异动，股价大幅上涨5.15%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Gri Bio, Inc.较为活跃，换手率分别为4076.12%、2854.85%、133.94%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Dermata Therapeutics, Inc.，振幅分别为365.43%、137.74%、51.54%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223429af93ac76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223429af93ac76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","BK4139","BK4539","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vervetx.com","stockEarnings":[{"period":"1week","weight":-0.145},{"period":"1month","weight":-0.1916},{"period":"3month","weight":-0.0688},{"period":"6month","weight":-0.1288},{"period":"1year","weight":-0.6179},{"period":"ytd","weight":-0.67}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verve Therapeutics, Inc.于2018年3月9日成立为特拉华州公司。他们是一家基因药物公司，开创了一种治疗心血管疾病或CVD的新方法，将治疗从慢性管理转变为单程基因编辑药物。他们认为，单疗程治疗可以为患有动脉粥样硬化性心血管疾病或ASCVD或有患动脉粥样硬化性心血管疾病风险的患者提供终生持续的显著健康益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.088813},{"month":2,"riseRate":0.666667,"avgChangeRate":0.181282},{"month":3,"riseRate":0,"avgChangeRate":-0.254413},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.262971},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049534},{"month":6,"riseRate":0.666667,"avgChangeRate":0.053142},{"month":7,"riseRate":0.75,"avgChangeRate":0.281218},{"month":8,"riseRate":0.5,"avgChangeRate":0.08013},{"month":9,"riseRate":0.25,"avgChangeRate":-0.170008},{"month":10,"riseRate":0.5,"avgChangeRate":0.044106},{"month":11,"riseRate":0,"avgChangeRate":-0.227378},{"month":12,"riseRate":0.666667,"avgChangeRate":0.050219}],"exchange":"NASDAQ","name":"Verve Therapeutics","nameEN":"Verve Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verve Therapeutics,VERV,Verve Therapeutics股票,Verve Therapeutics股票老虎,Verve Therapeutics股票老虎国际,Verve Therapeutics行情,Verve Therapeutics股票行情,Verve Therapeutics股价,Verve Therapeutics股市,Verve Therapeutics股票价格,Verve Therapeutics股票交易,Verve Therapeutics股票购买,Verve Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}